查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945504

2026年全球哺乳動物細胞庫市場報告

Mammalian Cell Banking Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，哺乳動物細胞庫市場發展迅速，預計將從2025年的31.4億美元成長到2026年的35億美元，複合年成長率達11.3%。過去幾年的成長要素包括單株抗體開發、疫苗生產擴張、監管品質要求、學術研究的擴展以及生物製藥的商業化。

預計未來幾年哺乳動物細胞庫市場將快速成長，到2030年市場規模將達到53.1億美元，複合年成長率（CAGR）為11.0%。預測期內的成長要素包括基因治療的進步、個人化醫療的擴展、生物相似藥的開發、細胞療法研發管線的拓展以及對長期細胞可追溯性的需求。預測期內的關鍵趨勢包括細胞株保存的標準化、生物製藥研發管線的擴展、符合現行藥品生產品質管理規範（CGMP）的細胞庫的擴張、對遺傳穩定性的日益重視以及外包給專業機構的增加。

對細胞療法日益成長的需求預計將顯著推動哺乳動物細胞庫市場的擴張。細胞療法是一種先進治療方法，它利用活細胞（通常經過改造或基因工程）來修復、替換或再生受損的組織和器官，從而為多種疾病提供標靶治療。慢性病和罕見疾病的增加促使人們需要更有效、更精準的治療方法。哺乳動物細胞庫在支持這些療法方面發揮著至關重要的作用，它們提供穩定、高品質的細胞來源，並確保再生醫學研發和生產的安全性、擴充性和可靠性。例如，美國基因與細胞治療方法學會 (ASGCT) 在 2024 年 4 月報告稱，處於臨床開發平臺的治療方法數量正在增加，尤其是 I 期臨床試驗的成長率高達 11%，為 2022 年底以來的最高水平。對細胞療法需求的激增正在推動哺乳動物細胞庫市場的成長。

哺乳動物細胞庫市場的企業正透過開發創新的穩定細胞株系統來推動該領域的發展，這些系統能夠提高細胞株的生產力，確保長期的遺傳穩定性，並簡化生物製藥生產流程。穩定細胞株系統是指經過基因工程改造的哺乳動物細胞，它們能夠在保持高度遺傳穩定性的同時，持續數代生產特定的蛋白質或治療分子。例如，總部位於中國的生物製藥公司藥明生物於2024年8月推出了WuXia293穩定細胞株平台。該平台基於HEK293細胞，專為開發和生產具有挑戰性的生物分子而設計。憑藉專有的細胞株開發技術，該平台能夠確保穩定的表達、一致的品質和可擴展的生產，克服了傳統CHO細胞系統常見的產量低和品質下降等問題。 WuXia293穩定細胞系平台能夠提供更高的蛋白質產量、更接近人源的糖基化修飾以及更有效率的生產，適用於臨床和商業應用。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球哺乳動物細胞庫市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 永續性、氣候技術和循環經濟
    • 人工智慧（AI）和自主人工智慧
  • 主要趨勢
    • 細胞株保存的標準化
    • 生物製藥研發管線的成長
    • 擴大符合CGMP標準的細胞庫
    • 日益關注遺傳穩定性
    • 增加外包給專業設施

第5章 終端用戶產業市場分析

  • 生物製藥公司
  • 學術研究機構
  • 合約研究機構
  • 疫苗生產商
  • 基因治療開發公司

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球哺乳動物細胞庫市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球哺乳動物細胞庫市場規模、對比及成長率分析
  • 全球哺乳動物細胞庫市場表現：規模與成長，2020-2025年
  • 全球哺乳動物細胞庫市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場總量（TAM）

第9章 市場細分

  • 依產品類型
  • 主細胞庫，工作細胞庫
  • 按細胞類型
  • 中國倉鼠卵巢細胞（CHO）、幼倉鼠腎細胞（BHK）、非分泌型0細胞（NS0）、YB2/0和P2/0、人類胚胎腎293細胞（HEK293）及其衍生、亨麗埃塔·拉克斯細胞（HELA）
  • 依儲存類型
  • 液態氮、速凍機、快速冷凍
  • 透過使用
  • 藥物研發、疫苗生產、基因治療、單株抗體生產
  • 最終用戶
  • 學術研究機構、生物製藥公司、受託研究機構（CRO）
  • 按類型細分：主細胞庫
  • 重組細胞株、融合瘤細胞株、原代細胞株、基因工程細胞株、病毒載體生產細胞株
  • 按類型細分：工作細胞庫
  • 符合現行良好生產規範 (CGMP) 的細胞庫、研究級細胞庫、臨床試驗細胞庫、商業生產細胞庫和穩定性測試細胞庫

第10章 區域與國家分析

  • 全球哺乳動物細胞庫市場：區域分析、預測及成長，2020-2025年、2025-2030年預測、2035年預測
  • 全球哺乳動物細胞庫市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 哺乳動物細胞庫市場：競爭格局及市場佔有率（2024年）
  • 哺乳動物細胞庫市場：公司估值矩陣
  • 哺乳動物細胞庫市場：公司概況
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Lonza Group AG
    • Eurofins Scientific SE
    • Charles River Laboratories International Inc.

第37章：其他領先和創新企業

  • Catalent Inc., Sartorius Stedim Biotech SA, Samsung Biologics Co Ltd, CMIC Holdings Co Ltd, WuXi Biologics Inc., Evotec SE, AGC Biologics Inc., GenScript ProBio Co Ltd, Syngene International Limited, KBI Biopharma Inc., Rentschler Biopharma SE, Polpharma Biologics SA, Abzena plc, 53Biologics, Cellistic

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年哺乳動物細胞庫市場：提供新機會的國家
  • 2030年哺乳動物細胞庫市場：新興細分市場機會
  • 2030年哺乳動物細胞庫市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MMCBE01_G26Q1

Mammalian cell banking is the organized procedure of producing, preserving, and storing well-characterized mammalian cell stocks under strict conditions, typically at very low temperatures, to ensure their long-term survival, genetic consistency, and functional performance. This method maintains the cells' uniformity, prevents contamination, and preserves their original traits over time, providing a reliable and standardized resource for future use.

The primary types of products in mammalian cell banking are master cell bank and working cell bank. A master cell bank (MCB) is a carefully prepared and extensively characterized collection of cells stored in multiple vials under controlled cryogenic conditions. It includes various cell types such as Chinese hamster ovary (CHO), baby hamster kidney (BHK), non-secreting 0 (NS0), YB2/0 and P2/0, human embryonic kidney 293 (HEK293) and derivatives, and HeLa cells. Storage methods include liquid nitrogen, controlled-rate freezing, and flash freezing. Master cell banks are used in drug development, vaccine production, gene therapy, and monoclonal antibody production, serving end users such as academic and research laboratories, biopharmaceutical companies, and contract research organizations (CROs).

Tariffs have influenced the mammalian cell banking market by raising costs for cryogenic equipment, storage systems, and specialized consumables sourced internationally. Biopharmaceutical production hubs in North America, Europe, and Asia-Pacific are most affected, particularly master and working cell bank segments. On the positive side, tariffs are driving domestic manufacturing investments, improved supply chain security, and regional cell banking infrastructure development.

The mammalian cell banking market research report is one of a series of new reports from The Business Research Company that provides mammalian cell banking market statistics, including mammalian cell banking industry global market size, regional shares, competitors with a mammalian cell banking market share, detailed mammalian cell banking market segments, market trends and opportunities, and any further data you may need to thrive in the mammalian cell banking industry. This mammalian cell banking market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mammalian cell banking market size has grown rapidly in recent years. It will grow from $3.14 billion in 2025 to $3.5 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to monoclonal antibody development, vaccine manufacturing growth, regulatory quality requirements, academic research expansion, biologics commercialization.

The mammalian cell banking market size is expected to see rapid growth in the next few years. It will grow to $5.31 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to gene therapy advancements, personalized medicine growth, biosimilar development, cell-based therapy pipelines, long-term cell traceability needs. Major trends in the forecast period include standardization of cell line preservation, growth of biopharmaceutical pipelines, expansion of CGMP-compliant cell banks, increased focus on genetic stability, rising outsourcing to specialized facilities.

The growing demand for cell-based therapies is expected to significantly drive the expansion of the mammalian cell banking market. Cell-based therapies involve advanced treatments using living, often modified or engineered, cells to repair, replace, or regenerate damaged tissues and organs, offering targeted solutions for various diseases. As chronic and rare diseases become more prevalent, there is an increasing need for more effective and precise treatments. Mammalian cell banking plays a key role in supporting these therapies by providing a consistent, high-quality cell source, ensuring safety, scalability, and reliability in the development and production of regenerative treatments. For example, the American Society of Gene and Cell Therapy reported in April 2024 that the number of therapies in clinical pipelines has grown, with Phase I trials showing the strongest growth of 11% since late 2022. This surge in demand for cell-based therapies is therefore fueling the growth of the mammalian cell banking market.

Companies in the mammalian cell banking market are advancing the field by developing innovative stable cell line systems that improve cell line productivity, ensure long-term genetic stability, and streamline biopharmaceutical manufacturing. Stable cell line systems are engineered mammalian cells that can consistently produce specific proteins or therapeutic molecules across generations with high genetic stability. For example, WuXi Biologics, a biopharmaceutical company based in China, introduced the WuXia293 Stable platform in August 2024. This HEK293-based stable cell line system is designed for the development and production of challenging biologic molecules. By using proprietary cell line development technology, the platform ensures stable expression, consistent quality, and scalable production, overcoming challenges typically seen with traditional CHO cell systems, such as low yields and compromised quality. The WuXia293 Stable platform provides higher protein yields, better human-like glycosylation, and more efficient production for clinical and commercial use.

In April 2025, Sartorius, a Germany-based life sciences technology provider, formed a strategic CDMO collaboration with Mabion S.A. to support comprehensive biopharmaceutical development using mammalian cell systems. This partnership enables Sartorius to enhance its capabilities in mammalian cell banking by combining advanced cell line development, upstream process optimization, and proprietary cell culture media with Mabion's GMP-compliant process development, scale-up, and large-scale biologics manufacturing. Mabion is a Poland-based biopharmaceutical CDMO focused on mammalian cell culture-based protein production and GMP manufacturing of both drug substances and drug products.

Major companies operating in the mammalian cell banking market are Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, Eurofins Scientific SE, Charles River Laboratories International Inc., Catalent Inc., Sartorius Stedim Biotech S A, Samsung Biologics Co Ltd, CMIC Holdings Co Ltd, WuXi Biologics Inc., Evotec SE, AGC Biologics Inc., GenScript ProBio Co Ltd, Syngene International Limited, KBI Biopharma Inc., Rentschler Biopharma SE, Polpharma Biologics S A, Abzena plc, 53Biologics, Cellistic, GBI Biomanufacturing, ABL Inc, OmniaBio, uBriGene Biosciences

North America was the largest region in the mammalian cell banking market in 2025. The regions covered in the mammalian cell banking market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mammalian cell banking market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The mammalian cell banking market consists of sales of cryopreservation media, cell culture reagents, storage vials, cryogenic storage equipment, and quality control kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mammalian Cell Banking Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses mammalian cell banking market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mammalian cell banking ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mammalian cell banking market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Master Cell Bank; Working Cell Bank
  • 2) By Cell Type: Chinese Hamster Ovary Mammalian Cell Banking (CHO); Baby Hamster Kidney (BHK); Non-Secreting 0 (NS0); YB2/0 And P2/0; Human Embryonic Kidney 293 (HEK293) And Derivatives; Henrietta Lacks (HELA)
  • 3) By Storage Type: Liquid Nitrogen; Controlled Rate Freezer; Flash Freezing
  • 4) By Application: Drug Development; Vaccine Production; Gene Therapy; Monoclonal Antibody Production
  • 5) By End User: Academic And Research Laboratories; Biopharmaceutical Companies; Contract Research Organizations (CROs)
  • Subsegments:
  • 1) By Master Cell Bank: Recombinant Cell Lines; Hybridoma Cell Lines; Primary Cell Lines; Genetically Engineered Cell Lines; Viral Vector Producing Cell Lines
  • 2) By Working Cell Bank: Current Good Manufacturing Practice (CGMP)-Compliant Cell Banks; Research-Grade Cell Banks; Clinical Trial Cell Banks; Commercial Production Cell Banks; Stability Testing Cell Banks
  • Companies Mentioned: Merck KGaA; Thermo Fisher Scientific Inc.; Lonza Group AG; Eurofins Scientific SE; Charles River Laboratories International Inc.; Catalent Inc.; Sartorius Stedim Biotech S A; Samsung Biologics Co Ltd; CMIC Holdings Co Ltd; WuXi Biologics Inc.; Evotec SE; AGC Biologics Inc.; GenScript ProBio Co Ltd; Syngene International Limited; KBI Biopharma Inc.; Rentschler Biopharma SE; Polpharma Biologics S A; Abzena plc; 53Biologics; Cellistic; GBI Biomanufacturing; ABL Inc; OmniaBio; uBriGene Biosciences
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Mammalian Cell Banking Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Mammalian Cell Banking Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Mammalian Cell Banking Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Mammalian Cell Banking Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Standardization Of Cell Line Preservation
    • 4.2.2 Growth Of Biopharmaceutical Pipelines
    • 4.2.3 Expansion Of Cgmp-Compliant Cell Banks
    • 4.2.4 Increased Focus On Genetic Stability
    • 4.2.5 Rising Outsourcing To Specialized Facilities

5. Mammalian Cell Banking Market Analysis Of End Use Industries

  • 5.1 Biopharmaceutical Companies
  • 5.2 Academic And Research Laboratories
  • 5.3 Contract Research Organizations
  • 5.4 Vaccine Manufacturers
  • 5.5 Gene Therapy Developers

6. Mammalian Cell Banking Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Mammalian Cell Banking Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Mammalian Cell Banking PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Mammalian Cell Banking Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Mammalian Cell Banking Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Mammalian Cell Banking Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Mammalian Cell Banking Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Mammalian Cell Banking Market Segmentation

  • 9.1. Global Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Master Cell Bank, Working Cell Bank
  • 9.2. Global Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chinese Hamster Ovary Mammalian Cell Banking (CHO), Baby Hamster Kidney (BHK), Non-Secreting 0 (NS0), YB2/0 And P2/0, Human Embryonic Kidney 293 (HEK293) And Derivatives, Henrietta Lacks (HELA)
  • 9.3. Global Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Liquid Nitrogen, Controlled Rate Freezer, Flash Freezing
  • 9.4. Global Mammalian Cell Banking Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug Development, Vaccine Production, Gene Therapy, Monoclonal Antibody Production
  • 9.5. Global Mammalian Cell Banking Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Academic And Research Laboratories, Biopharmaceutical Companies, Contract Research Organizations (CROs)
  • 9.6. Global Mammalian Cell Banking Market, Sub-Segmentation Of Master Cell Bank, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Recombinant Cell Lines, Hybridoma Cell Lines, Primary Cell Lines, Genetically Engineered Cell Lines, Viral Vector Producing Cell Lines
  • 9.7. Global Mammalian Cell Banking Market, Sub-Segmentation Of Working Cell Bank, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Current Good Manufacturing Practice (CGMP)-Compliant Cell Banks, Research-Grade Cell Banks, Clinical Trial Cell Banks, Commercial Production Cell Banks, Stability Testing Cell Banks

10. Mammalian Cell Banking Market Regional And Country Analysis

  • 10.1. Global Mammalian Cell Banking Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Mammalian Cell Banking Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Mammalian Cell Banking Market

  • 11.1. Asia-Pacific Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Mammalian Cell Banking Market

  • 12.1. China Mammalian Cell Banking Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Mammalian Cell Banking Market

  • 13.1. India Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Mammalian Cell Banking Market

  • 14.1. Japan Mammalian Cell Banking Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Mammalian Cell Banking Market

  • 15.1. Australia Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Mammalian Cell Banking Market

  • 16.1. Indonesia Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Mammalian Cell Banking Market

  • 17.1. South Korea Mammalian Cell Banking Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Mammalian Cell Banking Market

  • 18.1. Taiwan Mammalian Cell Banking Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Mammalian Cell Banking Market

  • 19.1. South East Asia Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Mammalian Cell Banking Market

  • 20.1. Western Europe Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Mammalian Cell Banking Market

  • 21.1. UK Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Mammalian Cell Banking Market

  • 22.1. Germany Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Mammalian Cell Banking Market

  • 23.1. France Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Mammalian Cell Banking Market

  • 24.1. Italy Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Mammalian Cell Banking Market

  • 25.1. Spain Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Mammalian Cell Banking Market

  • 26.1. Eastern Europe Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Mammalian Cell Banking Market

  • 27.1. Russia Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Mammalian Cell Banking Market

  • 28.1. North America Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Mammalian Cell Banking Market

  • 29.1. USA Mammalian Cell Banking Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Mammalian Cell Banking Market

  • 30.1. Canada Mammalian Cell Banking Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Mammalian Cell Banking Market

  • 31.1. South America Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Mammalian Cell Banking Market

  • 32.1. Brazil Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Mammalian Cell Banking Market

  • 33.1. Middle East Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Mammalian Cell Banking Market

  • 34.1. Africa Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Mammalian Cell Banking Market Regulatory and Investment Landscape

36. Mammalian Cell Banking Market Competitive Landscape And Company Profiles

  • 36.1. Mammalian Cell Banking Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Mammalian Cell Banking Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Mammalian Cell Banking Market Company Profiles
    • 36.3.1. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Mammalian Cell Banking Market Other Major And Innovative Companies

  • Catalent Inc., Sartorius Stedim Biotech S A, Samsung Biologics Co Ltd, CMIC Holdings Co Ltd, WuXi Biologics Inc., Evotec SE, AGC Biologics Inc., GenScript ProBio Co Ltd, Syngene International Limited, KBI Biopharma Inc., Rentschler Biopharma SE, Polpharma Biologics S A, Abzena plc, 53Biologics, Cellistic

38. Global Mammalian Cell Banking Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Mammalian Cell Banking Market

40. Mammalian Cell Banking Market High Potential Countries, Segments and Strategies

  • 40.1 Mammalian Cell Banking Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Mammalian Cell Banking Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Mammalian Cell Banking Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer